120 related articles for article (PubMed ID: 10746859)
1. Cardiovascular disease after renal transplantation.
Kasiske BL
Semin Nephrol; 2000 Mar; 20(2):176-87. PubMed ID: 10746859
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular disease after renal transplantation].
Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular complications after renal transplantation and their prevention.
Ojo AO
Transplantation; 2006 Sep; 82(5):603-11. PubMed ID: 16969281
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for cardiovascular disease after renal transplantation.
Kasiske BL
Miner Electrolyte Metab; 1993; 19(3):186-95. PubMed ID: 8232106
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of risk factors for cardiovascular disease in Brazilian renal transplant recipients.
Souza FC; Silva MI; Motta EM; Guimarães SS; Souza E; Torres MR
Transplant Proc; 2007 Mar; 39(2):446-8. PubMed ID: 17362755
[TBL] [Abstract][Full Text] [Related]
6. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
Ibis A; Akgül A; Ozdemir N; Colak T; Sezer S; Arat Z; Haberal M
Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors in renal transplantation--current controversies.
Marcén R
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii3-8. PubMed ID: 16815854
[TBL] [Abstract][Full Text] [Related]
10. Addressing cardiovascular disease in patients with renal disease.
Crook ED; Washington DO
Ethn Dis; 2002; 12(4):S3-1-4. PubMed ID: 12477146
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension after kidney transplantation].
Racki S
Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
[TBL] [Abstract][Full Text] [Related]
12. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
Ward HJ
J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cardiovascular disease in pediatric renal transplant recipients.
Silverstein DM
Pediatr Transplant; 2004 Aug; 8(4):386-93. PubMed ID: 15265167
[TBL] [Abstract][Full Text] [Related]
14. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.
Rogers CC; Alloway RR; Boardman R; Trofe J; Hanaway MJ; Alexander JW; Roy-Chaudhury P; Buell JF; Thomas M; Susskind B; Woodle ES
Transplant Proc; 2005 Mar; 37(2):812-3. PubMed ID: 15848540
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant management of end-stage renal disease patients to minimize posttransplant risk.
Jardine AG
Transplantation; 2000 Dec; 70(11 Suppl):SS46-50. PubMed ID: 11152231
[TBL] [Abstract][Full Text] [Related]
16. Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients.
Acikel S; Yildirir A; Aydinalp A; Demirtas K; Bal U; Kaynar G; Ozin B; Karakayali H; Muderrisoglu H; Haberal M
Transplant Proc; 2008 Dec; 40(10):3485-8. PubMed ID: 19100419
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in renal transplant recipients.
McQuarrie EP; Fellström BC; Holdaas H; Jardine AG
J Ren Care; 2010 May; 36 Suppl 1():136-45. PubMed ID: 20586909
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
19. How to decrease cardiovascular mortality in renal transplant recipients.
Ostovan MA; Fazelzadeh A; Mehdizadeh AR; Razmkon A; Malek-Hosseini SA
Transplant Proc; 2006 Nov; 38(9):2887-92. PubMed ID: 17112856
[TBL] [Abstract][Full Text] [Related]
20. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
